Fluoxetine Up-regulates Bcl-xL expression in rat C6 glioma cells

Psychiatry Investigation

Volumn 8, Issue 2, 2011, Pages 161-168

  Choi, Mi Ran ^b   Oh, Dong Hoon ^a   Kim, Seok Hyeon ^a   Yang, Byung Hwan ^a   Lee, Jun Seok ^c   Choi, Joonho ^a   Jeon, Hyun Soo ^a   Chai, Young Gyu ^b   Park, Yong Chon ^a  

^a Hanyang University   (South Korea)

^b Hanyang University   (South Korea)

^c KARF Hospital   (South Korea)

Author keywords

Antidepressant; Bcl xL; Fluoxetine; Gai2; Gsa; Microarray

Indexed keywords

CYCLIN G; FLUOXETINE; GAI2 PROTEIN; GSA PROTEIN; LIPOCORTIN 5; MESSENGER RNA; PROTEIN; PROTEIN BCL XL; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ANIMAL CELL; APOPTOSIS; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GLIOMA CELL; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; UPREGULATION; WESTERN BLOTTING;

EID: 79960944041     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2011.8.2.161     Document Type: Article

References (33)

1. Fuller RW, Wong DT, Robertson DW. Fluoxetine, a selective inhibitor of serotonin uptake. Med Res Rev 1991;11:17-34.
2. Wong DT, Bymaster FP, Engleman EA. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 1995;57:411-441.
3. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:85-102.
4. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996;16:2365-2372.
5. Chiou SH, Chen SJ, Peng CH, Chang YL, Ku HH, Hsu WM, et al. Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. Biochem Biophys Res Commun 2006;343:391-400.
6. Reagan LP, Hendry RM, Reznikov LR, Piroli GG, Wood GE, McEwen BS, et al. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur J Pharmacol 2007;565:68-75.
7. Reierson GW, Mastronardi CA, Licinio J, Wong ML. Repeated antidepressant therapy increases cyclic GMP signaling in rat hippocampus. Neurosci Lett 2009;466:149-153.
8. Baik SY, Jung KH, Choi MR, Yang BH, Kim SH, Lee JS, et al. Fluoxetine- induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells. Neurosci Lett 2005;374:53-57.
9. Páv M, Kováru H, Fiserová A, Havrdová E, Lisá V. Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia. Physiol Res 2008;57:151-164.
10. Chen J, Rasenick MM. Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase. J Neurochem 1995;64:724-732.
11. Roh K, Roh S, Yang BH, Lee JS, Chai YG, Choi MR, et al. Effects of haloperidol and risperidone on the expression of heat shock protein 70 in MK-801-treated rat C6 glioma cells. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1793-1797.
12. Elliott JM, Newberry NR, Cholewinski AJ, Bartrup JT, Briddon SJ, Carey JE, et al. Characterization of the 5-hydroxytryptamine2A receptoractivated cascade in rat C6 glioma cells. Neuroscience 1995;69:1119-1131.
13. Thomas EA, Matli JR, Hu JL, Carson MJ, Sutcliffe JG. Pertussis toxin treatment prevents 5-HT(5a) receptor-mediated inhibition of cyclic AMP accumulation in rat C6 glioma cells. J Neurosci Res 2000;61:75-81.
14. Donati RJ, Thukral C, Rasenick MM. Chronic treatment of C6 glioma cells with antidepressant drugs results in a redistribution of Gsalpha. Mol Pharmacol 2001;59:1426-1432.
15. Choi MR, Baik SY, Jung KH, Chai YG, Kim SH, Roh S, et al. Characterization of differentially expressed genes upon chronic fluoxetine treatment in rat C6 glioma cells. Korean J Psychopharmacol 2004;15:457-467.
16. Greener T, Zhao X, Nojima H, Eisenberg E, Greene LE. Role of cyclin G-associated kinase in uncoating clathrin-coated vesicles from non-neuronal cells. J Biol Chem 2000;275:1365-1370.
17. Umeda A, Meyerholz A, Ungewickell E. Identification of the universal cofactor (auxilin 2) in clathrin coat dissociation. Eur J Cell Biol 2000;79: 336-342.
18. Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 1994;54:5501-5507.
19. Emamghoreishi M, Warsh JJ, Sibony D, Li PP. Lack of effect of chronic antidepressant treatment on Gs and Gi alpha-subunit protein and mRNA levels in the rat cerebral cortex. Neuropsychopharmacology 1996;15:281-287.
20. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999;46:1181-1191.
21. McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci 1999; 22:105-122.
22. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT. G Protein- coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 1999;73:1121-1126.
23. Ozawa H, Rasenick MM. Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem 1991;56:330-338.
24. Toki S, Donati RJ, Rasenick MM. Treatment of C6 glioma cells and rats with antidepressant drugs increases the detergent extraction of G (s alpha) from plasma membrane. J Neurochem 1999;73:1114-1120.
25. Benson DL, Schnapp LM, Shapiro L, Huntley GW. Making memories stick: cell-adhesion molecules in synaptic plasticity. Trends Cell Biol 2000; 10:473-482.
26. Sandi C. Stress, cognitive impairment and cell adhesion molecules. Nat Rev Neurosci 2004;5:917-930.
27. Buttner B, Reutter W, Horstkorte R. Cytoplasmic domain of NCAM180 reduces NCAM-mediated neurite outgrowth. J Neurosci Res 2004; 75:854-860.
28. Wakabayashi Y, Uchida S, Funato H, Matsubara T, Watanuki T, Otsuki K, et al. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1199-1205.
29. Meers P, Mealy T. Calcium-dependent annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative charge. Biochemistry 1993;32:11711-11721.
30. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1999;286:2358-2361.
31. Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nat Med 2001;7:541-547.
32. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000; 407:802-809.
33. Kosten TA, Galloway MP, Duman RS, Russell DS, D'Sa C. Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 2008;33:1545-1558.